Armistice Capital LLC Purchases 156,870 Shares of Crocs, Inc. $CROX

Armistice Capital LLC grew its holdings in Crocs, Inc. (NASDAQ:CROXFree Report) by 468.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 190,350 shares of the textile maker’s stock after purchasing an additional 156,870 shares during the quarter. Armistice Capital LLC owned approximately 0.38% of Crocs worth $16,279,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CROX. Cetera Investment Advisers lifted its holdings in Crocs by 10.3% in the fourth quarter. Cetera Investment Advisers now owns 25,393 shares of the textile maker’s stock valued at $2,172,000 after buying an additional 2,365 shares during the period. Incision Capital Management LP acquired a new stake in Crocs during the 4th quarter worth $27,794,000. Trexquant Investment LP acquired a new stake in Crocs during the 4th quarter worth $548,000. Amundi bought a new stake in shares of Crocs during the 4th quarter valued at $353,000. Finally, Sciencast Management LP lifted its stake in shares of Crocs by 100.1% in the 4th quarter. Sciencast Management LP now owns 38,988 shares of the textile maker’s stock valued at $3,334,000 after purchasing an additional 19,508 shares during the period. Institutional investors and hedge funds own 93.44% of the company’s stock.

Insider Buying and Selling

In other Crocs news, CEO Andrew Rees sold 32,688 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $118.09, for a total value of $3,860,125.92. Following the sale, the chief executive officer owned 743,293 shares in the company, valued at approximately $87,775,470.37. The trade was a 4.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CROX. Royal Bank Of Canada began coverage on Crocs in a research note on Monday, June 8th. They set an “overweight” rating for the company. Barclays raised their target price on Crocs from $109.00 to $110.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. BTIG Research initiated coverage on Crocs in a research note on Tuesday, March 10th. They issued a “neutral” rating for the company. The Goldman Sachs Group downgraded shares of Crocs from a “sell” rating to a “neutral” rating in a research report on Monday, June 8th. Finally, Stifel Nicolaus lifted their price objective on shares of Crocs from $105.00 to $125.00 and gave the stock a “hold” rating in a research note on Monday. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Crocs has a consensus rating of “Moderate Buy” and a consensus price target of $120.00.

Check Out Our Latest Report on Crocs

Crocs Price Performance

Shares of NASDAQ CROX opened at $124.53 on Thursday. The company has a fifty day moving average price of $108.79 and a 200 day moving average price of $94.31. The firm has a market cap of $6.19 billion, a PE ratio of -90.24, a PEG ratio of 1.31 and a beta of 1.57. The company has a current ratio of 1.67, a quick ratio of 1.04 and a debt-to-equity ratio of 0.93. Crocs, Inc. has a 1-year low of $73.21 and a 1-year high of $129.79.

Crocs (NASDAQ:CROXGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The textile maker reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.78 by $0.21. The firm had revenue of $921.46 million for the quarter, compared to the consensus estimate of $900.57 million. Crocs had a positive return on equity of 48.29% and a negative net margin of 2.58%.The company’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the business posted $3.00 EPS. Crocs has set its Q2 2026 guidance at 4.150-4.350 EPS and its FY 2026 guidance at 13.200-13.750 EPS. Research analysts predict that Crocs, Inc. will post 13.67 earnings per share for the current fiscal year.

Crocs Profile

(Free Report)

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.

See Also

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.